In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Neurobiology of Aging

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 1461341
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alzheimer's retraction

  1992cited by this paper
• beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity

  1992cited by this paper
• Age-associated inclusions in normal and transgenic mouse brain.

  1992cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis.

  1992cited by this paper
• Brain transplants of cells expressing the carboxyl-terminal fragment of the Alzheimer amyloid protein precursor cause specific neuropathology in vivo.

  1992cited by this paper
• Neurochemical characterization of excitotoxin lesions in the cerebral cortex

  1991cited by this paper
• In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity.

  1991cited by this paper
• Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

  1991cited by this paper
• Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene

  1991cited by this paper
• Seminars in medicine of the Beth Israel Hospital, Boston. beta-Amyloid and the pathogenesis of Alzheimer's disease.

  1991cited by this paper
• Effects of injected Alzheimer beta-amyloid cores in rat brain.

  1991cited by this paper
• An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P.

  1991cited by this paper
• Chronic quinolinic acid lesions in rats closely resemble Huntington's disease

  1991cited by this paper
• Substance P-like immunoreactive neurons are depleted in Alzheimer's disease cerebral cortex.

  1991cited by this paper
• The molecular pathology of Alzheimer's disease.

  1991cited by this paper
• Neuritic pathology and dementia in alzheimer's disease

  1991cited by this paper
• Mis-sense mutation Val----Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease.

  1991cited by this paper
• Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

  1990cited by this paper
• Degeneration of pyramidal projection neurons in Huntington's disease cortex

  1990cited by this paper
• The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome.

  1989cited by this paper
• Monoclonal antibody to neurofilament protein (SMI‐32) labels a subpopulation of pyramidal neurons in the human and monkey neocortex

  1989cited by this paper

• Restoring neuronal excitability and spatial memory through inhibiting amyloid-β-induced hyperactive NF-κB in a rat model of Alzheimer's disease.

  2025cites this paper
• Inflammation and DNA methylation in Alzheimer’s disease: mechanisms of epigenetic remodelling by immune cell oxidants in the ageing brain

  2024cites this paper
• Protective effect of Ganoderma lucidum-fermented crop extracts against hydrogen peroxide- or β-amyloid-induced damage in human neuronal SH-SY5Y cells

  2024cites this paper
• Sink or swim: Does a worm paralysis phenotype hold clues to neurodegenerative disease?

  2023cites this paper
• Tau-targeting therapies for Alzheimer disease: current status and future directions

  2023cites this paper
• Microglial inflammation and cognitive dysfunction in comorbid rat models of striatal ischemic stroke and alzheimer's disease: effects of antioxidant catalase-SKL on behavioral and cellular pathology.

  2022cites this paper
• Annexin A5 prevents amyloid-β-induced toxicity in choroid plexus: implication for Alzheimer’s disease

  2020cites this paper
• Amyloidogenic Intrinsically Disordered Proteins: New Insights into Their Self-Assembly and Their Interaction with Membranes

  2020cites this paper
• Protective role of phenylethanoid glycosides, Torenoside B and Savatiside A, in Alzheimer's disease.

  2019cites this paper
• The antioxidant xanthorrhizol prevents amyloid-β-induced oxidative modification and inactivation of neprilysin

  2018cites this paper
• Neuronal susceptibility to beta‐amyloid toxicity and ischemic injury involves histone deacetylase‐2 regulation of endophilin‐B1

  2018cites this paper
• The developing utility of zebrafish models of neurological and neuropsychiatric disorders: A critical review

  2018cites this paper
• N-3 Polyunsaturated Fatty Acids and Neuroinflammation in Alzheimer's Disease

  2017cites this paper
• Sigma-1 Receptor Agonists Induce Oxidative Stress in Mitochondria and Enhance Complex I Activity in Physiological Condition but Protect Against Pathological Oxidative Stress

  2017cites this paper
• Molecular and cellular mechanisms of sporadic Alzheimer’s disease: Studies on rodent models in vivo

  2017cites this paper
• Impact of enriched environment on production of tau, amyloid precursor protein and, amyloid-β peptide in high-fat and high-sucrose-fed rats

  2016cites this paper
• Subtle learning and memory impairment in an idiopathic rat model of Alzheimer's disease utilizing cholinergic depletions and β-amyloid.

  2016cites this paper
• Estradiol prevents Aβ25 35-inhibited long-term potentiation induction through enhancing survival of newborn neurons in the dentate gyrus

  2016cites this paper
• Humanized Tau Mice with Regionalized Amyloid Exhibit Behavioral Deficits but No Pathological Interaction

  2016cites this paper
• Age‐Dependent Effect of β‐Amyloid Toxicity on Basal Forebrain Cholinergic Neurons and Inflammation in the Rat Brain

  2015cites this paper
• Neuroprotective Role of Novel Triazine Derivatives by Activating Wnt/β Catenin Signaling Pathway in Rodent Models of Alzheimer’s Disease

  2015cites this paper
• Selective activation of α7 nicotinic acetylcholine receptor by PHA-543613 improves Aβ25-35-mediated cognitive deficits in mice.

  2015cites this paper
• Acute Exposure of the Mediobasal Hypothalamus to Amyloid-β25-35 Perturbs Hepatic Glucose Metabolism

  2015cites this paper
• The Effects of Multiple Injections of BA(25-35) into the Medial Septal Area on Spatial Learning in the Male Rat

  2015cites this paper
• Tenuifolin, a secondary saponin from hydrolysates of polygalasaponins, counteracts the neurotoxicity induced by Aβ25-35 peptides in vitro and in vivo.

  2015cites this paper
• Impaired electro-genesis in skeletal muscle fibers of transgenic Alzheimer mice.

  2014cites this paper
• The role of intracellular zinc release in aging, oxidative stress, and Alzheimer’s disease

  2014cites this paper
• Simvastatin Exerts Antiamnesic Effect in Aβ25‐35‐Injected Mice

  2014cites this paper
• Impact of Amyloid β25-35 on Membrane Stability, Energy Metabolism, and Antioxidant Enzymes in Erythrocytes

  2014cites this paper
• Schisandrin B Enhances Glutathione Redox Cycling and Protects Against β-amyloid-induced Apoptosis in Human Neuroblastoma SH-SY5Y Cells: A Comparative Study of Various Phytochemicals

  2014cites this paper
• Investigating the pathological response to beta amyloid toxicity in rats: the role of age and the antioxidant catalase-SKL

  2013cites this paper
• Estradiol prevents olfactory dysfunction induced by A-β 25–35 injection in hippocampus

  2013cites this paper
• Glaucoma and Alzheimer’s Disease – Common Pathomechanisms and Therapeutic Measures

  2013cites this paper
• Ionic and Molecular Mechanisms of β-Amyloid-Induced Depolarization in Mouse Skeletal Muscle Fibers

  2013cites this paper
• Neuroprotection Against Oxidative Injury by a Nucleic Acid–Based Health Product (Squina DNA) Through Enhancing Mitochondrial Antioxidant Status and Functional Capacity

  2012cites this paper
• β‐amyloid peptide is internalized into chick retinal neurons and alters the distribution of myosin Vb

  2012cites this paper
• Pimavanserin, a 5-HT2A receptor inverse agonist, reverses psychosis-like behaviors in a rodent model of Alzheimer’s disease

  2012cites this paper
• Anti-amnesic effect of neurosteroid PREGS in Aβ25-35-injected mice through σ1 receptor- and α7nAChR-mediated neuroprotection.

  2012cites this paper
• An investigation into the combined effects of β-amyloid toxicity and cerebral ischemia on the pathological expression of gangliosides.

  2012cites this paper
• Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer disease subjects

  2011cites this paper
• Amyloid-β induced toxicity involves ganglioside expression and is sensitive to GM1 neuroprotective action.

  2011cites this paper
• Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects.

  2011cites this paper
• Extraneuronal toxicity of Alzheimer's β‐amyloid peptide: Comparative study on vertebrate skeletal muscles

  2011cites this paper
• TEMPOL protects human neuroblastoma SH-SY5Y cells against β-amyloid-induced cell toxicity.

  2011cites this paper
• Inhibition of HSP90‐dependent telomerase activity in amyloid β‐induced apoptosis of cerebral endothelial cells

  2011cites this paper
• Microcebus murinus retina: a new model to assess prion-related neurotoxicity in primates.

  2010cites this paper
• DMXB (GTS‐21) ameliorates the cognitive deficits in beta amyloid  25–35 − injected mice through preventing the dysfunction of alpha7 nicotinic receptor

  2010cites this paper
• Protective effect of systemic L-kynurenine and probenecid administration on behavioural and morphological alterations induced by toxic soluble amyloid beta (25-35) in rat hippocampus.

  2010cites this paper
• Abeta(25-35) as proxyholder for amyloidogenic peptides: in vivo evidence.

  2010cites this paper
• N-Acetylcysteine Prevents 4-Hydroxynonenal- and Amyloid-β-Induced Modification and Inactivation of Neprilysin in SH-SY5Y Cells

  2010cites this paper
• Astaxanthine Secured Apoptotic Death of PC12 Cells Induced by β-Amyloid Peptide 25–35: Its Molecular Action Targets

  2010cites this paper
• Modulation of amyloid beta peptide(1-42) cytotoxicity and aggregation in vitro by glucose and chondroitin sulfate.

  2010cites this paper
• Amyloid-β Decreases Nitric Oxide Production in Cultured Retinal Neurons: A Possible Mechanism for Synaptic Dysfunction in Alzheimer’s Disease?

  2010cites this paper
• Amyloid β-peptide directly induces spontaneous calcium transients, delayed intercellular calcium waves and gliosis in rat cortical astrocytes

  2009cites this paper
• Effects of HNE‐modification induced by Aβ on neprilysin expression and activity in SH‐SY5Y cells

  2009cites this paper
• The anti-amnesic effects of luteolin against amyloid beta(25-35) peptide-induced toxicity in mice involve the protection of neurovascular unit.

  2009cites this paper
• Dementia of the Alzheimer type.

  2008cites this paper
• p75NTR Antagonistic Cyclic Peptide Decreases the Size of β Amyloid-Induced Brain Inflammation

  2008cites this paper
• Targeting amyloid-beta in glaucoma treatment.

  2007cites this paper
• Swedish amyloid precursor protein mutation increases phosphorylation of eIF2alpha in vitro and in vivo.

  2007cites this paper
• Impairments of hippocampal synaptic plasticity induced by aggregated beta-amyloid (25–35) are dependent on stimulation-protocol and genetic background

  2007cites this paper
• Protective effects and mechanism of total coptis alkaloids on A β25–35 induced learning and memory dysfunction in rats

  2007cites this paper
• The effects of chronic estradiol treatment on working memory deficits induced by combined infusion of beta-amyloid (1-42) and ibotenic acid.

  2007cites this paper
• Swedish amyloid precursor protein mutation increases phosphorylation of eIF2α in vitro and in vivo

  2007cites this paper
• Beta-amyloid peptide toxicity in organotypic hippocampal slice culture involves Akt/PKB, GSK-3beta, and PTEN.

  2007cites this paper
• Amyloid-β in Alzheimer Disease: The Null versus the Alternate Hypotheses

  2007cites this paper
• Soluble amyloid beta1-42 reduces dopamine levels in rat prefrontal cortex: relationship to nitric oxide.

  2007cites this paper
• The anti‐amnesic and neuroprotective effects of donepezil against amyloid β25‐35 peptide‐induced toxicity in mice involve an interaction with the σ1 receptor

  2006cites this paper
• Neuronal dysfunction in Down syndrome: contribution of neuronal models in cell culture.

  2006cites this paper
• Inflammatory cytokines and NFκB in Alzheimer’s disease.

  2006cites this paper
• Cognitive dysfunction induced by sequential injection of amyloid-beta and ibotenate into the bilateral hippocampus; protection by memantine and MK-801.

  2006cites this paper
• Nogo-A Expression in the Human Hippocampus in Normal Aging and in Alzheimer Disease

  2006cites this paper
• Development of Beta-Amyloid-induced Neurodegeneration in Alzheimer's Disease and Novel Neuroprotective Strategies

  2005cites this paper
• Oxidative stress induced by beta-amyloid peptide(1-42) is involved in the altered composition of cellular membrane lipids and the decreased expression of nicotinic receptors in human SH-SY5Y neuroblastoma cells.

  2005cites this paper
• Activation of GABA(A) receptors by taurine and muscimol blocks the neurotoxicity of beta-amyloid in rat hippocampal and cortical neurons.

  2005cites this paper
• Development of a Femtomolar-Acting Humanin Derivative Named Colivelin by Attaching Activity-Dependent Neurotrophic Factor to Its N Terminus: Characterization of Colivelin-Mediated Neuroprotection against Alzheimer's Disease-Relevant Insults In Vitro and In Vivo

  2005cites this paper
• Intraneuronal β-Amyloid Expression Downregulates the Akt Survival Pathway and Blunts the Stress Response

  2005cites this paper
• amilóide de Alzheimer The effect of cellular stress on the Alzheimer ́s amyloid precursor protein

  2005cites this paper
• A subset of calretinin-positive neurons are abnormal in Alzheimer's disease

  2004cites this paper
• Presence of non-fibrillar amyloid β protein in skin biopsies of Alzheimer's disease (AD), Down's syndrome and non-AD normal persons

  2004cites this paper
• BEHAVIORAL AND NEUROCHEMICAL EFFECTS OF THE INTRAHIPPOCAMPAL CO-INJECTION OF ß-AMYLOID PROTEIN1-40 AND IBOTENIC ACID IN RATS

  2004cites this paper
• Alzheimer's disease--a sum greater than its parts?

  2004cites this paper
• Glycosaminoglycan C3 protects against AF64A-induced cholinotoxicity in a dose-dependent and time-dependent manner.

  2004cites this paper
• Architecture of the Alzheimer's A beta P ion channel pore.

  2004cites this paper
• Effect of ginkgolides on beta-amyloid-suppressed acetylocholine release from rat hippocampal slices.

  2004cites this paper
• Active clearance of human amyloid β 1–42 peptide aggregates from the rat ventricular system

  2004cites this paper
• β-Amyloid Treatment Sensitizes Mice to Amphetamine-Induced Locomotion but Reduces Response to Caffeine

  2004cites this paper
• Taurine prevents the neurotoxicity of β‐amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders

  2004cites this paper
• Effects of amyloid-beta on cholinergic and acetylcholinesterase-positive cells in cultured basal forebrain neurons of embryonic rat brain.

  2004cites this paper
• Administration of Aggregated Beta-Amyloid Peptide (25–35) Induces Changes in Long-Term Potentiation in the Hippocampus in Vivo

  2003cites this paper
• Single intracerebroventricular administration of amyloid-beta (25-35) peptide induces impairment in short-term rather than long-term memory in rats.

  2003cites this paper
• Loss of nicotinic receptors induced by beta‐amyloid peptides in PC12 cells: Possible mechanism involving lipid peroxidation

  2003cites this paper
• Deposits of fibrillar A beta do not cause neuronal loss or ferritin expression in adult rat brain.

  2003cites this paper
• Amphotericin B binds to amyloid fibrils and delays their formation: a therapeutic mechanism?

  2003cites this paper
• The Production of Amyloid β Peptide Is a Critical Requirement for the Viability of Central Neurons

  2003cites this paper
• Effects of tumor necrosis factor‐alpha central administration on hippocampal damage in rat induced by amyloid beta‐peptide (25–35)

  2003cites this paper
• Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging

  2003cites this paper
• Serial Review : Causes and Consequences of Oxidative Stress in Alzheimer ’ s Disease

  2002cites this paper
• Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Abeta(25-35)-induced abnormal tau protein immunoreactivity in rat brain.

  2002cites this paper
• Evidence for D-aspartyl-beta-amyloid secretase activity in human brain.

  2002cites this paper